The Motley FoolThere's More to Gilead Sciences' Remdesivir Data Than Meets the EyeApr 20, 2020more_vert
Chemical & Engineering NewsScaling up remdesivir amid the coronavirus crisisApr 20, 2020Lisa JarvisBy Lisa Jarvismore_vert